CLINICAL_TRIALS
trial_result
· 2012-09-05
Clinical Trial Update: Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial evaluating dehydroepiandrosterone (DHEA) for Premature Ovarian Failure was terminated. Results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David H. Barad | Conditions: Premature Ovarian Failure | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2012-09-05